Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT06084039
Other study ID # 05-2023-067
Secondary ID
Status Completed
Phase
First received
Last updated
Start date August 1, 2022
Est. completion date September 25, 2023

Study information

Verified date October 2023
Source Pusan National University Yangsan Hospital
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

Inhalation anesthetics, such as desflurane, are identified as contributors to global warming, with the European Union planning to ban desflurane in 2026 due to its impact. The World Federation of Societies of Anesthesiologists (WFSA) has published guidelines to reduce air pollution related to inhalation anesthetics. Inhalation anesthetics account for a significant portion of carbon dioxide equivalent (CO2e) emissions in hospitals and surgery. Various anesthetics have different global warming potentials (GWP100), with desflurane having the highest GWP100. Nitrous oxide and isoflurane, although having lower GWP100, can also impact the environment negatively. Studies have shown that educating anesthesia staff about the environmental impact of desflurane and nitrous oxide can lead to significant reductions in their usage, resulting in lower CO2e emissions and cost savings. However, in some regions like Korea, awareness of the environmental impact of inhalation anesthetics is limited. The authors plan to analyze the impact of education on anesthesiologists regarding inhalation anesthetics and assess changes in their usage and CO2e emissions in clinical settings. The goal is to demonstrate that education can positively influence environmental outcomes and reduce economic losses.


Description:

Environmental issues are a global concern and a problem that everyone must solve together. Recently, there have been efforts to reduce carbon footprint in the medical field. In the field of anesthesiology, as it became known that inhalation anesthetics have a significant impact on global warming, the European Union officially declared in 2022 to ban the use of the inhalation anesthetic desflurane from 2026. Additionally, the World Federation of Societies of Anesthesiologists (WFSA) published guidelines on the use of inhalation anesthetics to reduce air pollution in 2022. Inhalation anesthetics are known to account for 0.01-0.1% of the total carbon dioxide equivalent (CO2e) contribution to global warming. This is 5% of hospital CO2e and 50% of surgery-related CO2e. Only 5% of the inhalation anesthetic is metabolized in the patient's body, and the remaining 95% is discharged through the anesthetic gas scavenging system of the anesthesia machine and released into the atmosphere without any additional post-processing. Representative inhalation anesthetics that are currently widely used include nitrous oxide (N2O), sevoflurane, desflurane, and isoflurane. Comparing their global warming potential (global warming potential 100, GWP100; which indicates the degree of greenhouse gas effect compared to CO2 over 100 years), nitrous oxide 298, sevoflurane 130, desflurane 2540, and isoflurane 510. Among these, desflurane shows the highest GWP100 and is presumed to be due to its high minimum alveolar concentration. In addition, nitrous oxide and isoflurane have relatively low global warming potential, but they can destroy ozone and, in particular, nitrous oxide has a half-life of 114 years, so it can stay in the atmosphere for a long time and affect global warming. Several studies have reported significant reductions in CO2e and medical costs along with a reduction in the use of these two anesthetics after educating anesthesia staff on the use of desflurane and nitrous oxide. In one study, desflurane usage was reduced by 95.63% and CO2e was reduced by 87.88%. In another study, desflurane use was reduced from 8.3% to 0.3%, CO2e was reduced from 1,681 to 10, and medical costs were saved by $200,000 over 3 years. In Korea, sevoflurane and desflurane are the most used, but the impact of inhalation anesthetics on global warming is not well-known to clinicians, and there are no related studies. After educating anesthesiologists about the impact of inhalation anesthetics on global warming, the investigators analyzed the use of inhalation anesthetics and changes in CO2e before and after education in actual clinical situations to determine whether education alone could reduce their use. In addition, the investigators aim to show that this can have a positive impact on global warming and economic losses. Education on the effects of inhalation anesthetics on global warming was conducted for every anesthesiologist in our hospital, and only medical records were reviewed retrospectively to confirm if there were any changes in choice of inhalation anesthetic, and fresh gas flow before and after receiving the training. Inevitably, patients for whom general anesthesia was performed by untrained anesthesiologists about the effects of inhalation anesthetics on global warming were excluded from the analysis. This is an observational study because there is no intervention applied to the patient, and patients not included in the study are also administered general anesthesia using the same method.


Recruitment information / eligibility

Status Completed
Enrollment 4478
Est. completion date September 25, 2023
Est. primary completion date February 28, 2023
Accepts healthy volunteers No
Gender All
Age group N/A and older
Eligibility Inclusion Criteria: - Patients who underwent surgery under general anesthesia performed for 1 month before and after education on the effects of inhalation anesthetics on global warming Exclusion Criteria: - Surgery performed under regional anesthesia - Surgery performed under total intravenous anesthesia - When the type of inhalation anesthetic is changed during surgery - Short surgery within 1 hour - In case of anesthesia by an anesthesiologist who did not attend the education on the effects of inhalation anesthetics on global warming

Study Design


Related Conditions & MeSH terms


Locations

Country Name City State
Korea, Republic of Pusan National University Yangsan Hospital Yangsan

Sponsors (1)

Lead Sponsor Collaborator
Pusan National University Yangsan Hospital

Country where clinical trial is conducted

Korea, Republic of, 

Outcome

Type Measure Description Time frame Safety issue
Primary Concentration of inhalation anesthetic used to maintain general anesthesia It is calculated using the average value of the inhalation anesthetic concentration and fresh gas flow rate during the entire anesthesia time, excluding 15 minutes after the start of general anesthesia and 15 minutes before the end of anesthesia. The formula for calculating the total amount of inhalation anesthetic is as follows.
Total amount of inhalation anesthetic used (mL)=([(Fresh gas flow rate (L/min)*1000)*(concentration of inhalation anesthetic (vol%))]/ Density (kg/cm3))* duration of anesthesia (hrs)
Amount of sevoflurane used per hour (mL)
([((MW (kg/mol)*(FGF (L/min)*1000)*(concentration of sevoflurane (vol%)/100)/24400)/1000]*60)/ Density (kg/cm3)
[(200 *(FGF*1000)*(vol%/100)/24400)/1000]*60/ 0.00152
Amount of desflurane used per hour (mL)
([((MW (kg/mol)*(FGF (L/min)*1000)*(concentration of desflurane (vol%)/100)/24400)/1000]*60)/ Density (kg/cm3)
[(168 *(FGF*1000)*(vol%/100)/24400)/1000]*60/ 0.001465
Total time for general anesthesia, up to 24hours
Primary Fresh gas flow rate used to maintain general anesthesia It is calculated using the average value of the inhalation anesthetic concentration and fresh gas flow rate during the entire anesthesia time, excluding 15 minutes after the start of general anesthesia and 15 minutes before the end of anesthesia. The formula for calculating the total amount of inhalation anesthetic is as follows.
Total amount of inhalation anesthetic used (mL)=([(Fresh gas flow rate (L/min)*1000)*(concentration of inhalation anesthetic (vol%))]/ Density (kg/cm3))* duration of anesthesia (hrs)
Amount of sevoflurane used per hour (mL)
([((MW (kg/mol)*(FGF (L/min)*1000)*(concentration of sevoflurane (vol%)/100)/24400)/1000]*60)/ Density (kg/cm3)
[(200 *(FGF*1000)*(vol%/100)/24400)/1000]*60/ 0.00152
Amount of desflurane used per hour (mL)
([((MW (kg/mol)*(FGF (L/min)*1000)*(concentration of desflurane (vol%)/100)/24400)/1000]*60)/ Density (kg/cm3)
[(168 *(FGF*1000)*(vol%/100)/24400)/1000]*60/ 0.001465
Total time for general anesthesia, up to 24hours
Secondary CO2e (total carbon dioxide equivalent), driving equivalent (equivalent driving distance, distance traveled by car to generate the same amount of greenhouse gases), and medical costs incurred due to the use of inhalation anesthetics Based on data examined from medical records, CO2e (total carbon dioxide equivalent), driving equivalent (equivalent driving distance, distance required to drive to generate the same amount of greenhouse gases), and medical costs incurred due to inhalation anesthetics were calculated by Anesthesia cost calculator (https://jscalc.io/calc/do45BOJVrzXMaEGC). The formulas for calculating CO2e (total carbon dioxide equivalent), and driving equivalent are as follows.
CO2e (kg) =130 * 200* ((FGF*1000)*(concentration of inhalation anesthetic /100)/24400/1000)*60* duration of anesthesia
driving equivalent (km) = CO2e *3.922
Total time for general anesthesia, up to 24hours
See also
  Status Clinical Trial Phase
Active, not recruiting NCT04279054 - Decreased Neuraxial Morphine After Cesarean Delivery Early Phase 1
Active, not recruiting NCT04580030 - Tricuapid Annular Plane Sistolic Excursion Before General Anesthesia Can Predict Hypotension After Induction
Completed NCT03640442 - Modified Ramped Position for Intubation of Obese Females. N/A
Recruiting NCT04099693 - A Prospective Randomized Study of General Anesthesia Versus Anesthetist Administered Sedation for ERCP
Terminated NCT02481999 - Pre- and Postoperative EEG-Monitoring for Children Aged From 0,5 to 8 Years
Completed NCT04235894 - An Observer Rating Scale of Facial Expression Can Predict Dreaming in Propofol Anesthesia
Recruiting NCT05525104 - The Effect of DSA on Recovery of Anaesthesia in Children (Het Effect Van DSA op Het Herstel na Anesthesie Bij Kinderen). N/A
Recruiting NCT05024084 - Desflurane and Sevoflurane Minimal Flow Anesthesia on Recovery and Anesthetic Depth Phase 4
Completed NCT04204785 - Noise in the OR at Induction: Patient and Anesthesiologists Perceptions N/A
Completed NCT03277872 - NoL, HR and MABP Responses to Tracheal Intubation Performed With MAC Blade Versus Glidescope N/A
Terminated NCT03940651 - Cardiac and Renal Biomarkers in Arthroplasty Surgery Phase 4
Terminated NCT02529696 - Measuring Sedation in the Intensive Care Unit Using Wireless Accelerometers
Completed NCT05346588 - THRIVE Feasibility Trial Phase 3
Terminated NCT03704285 - Development of pk/pd Model of Propofol in Patients With Severe Burns
Recruiting NCT05259787 - EP Intravenous Anesthesia in Hysteroscopy Phase 4
Completed NCT02894996 - Does the Response to a Mini-fluid Challenge of 3ml/kg in 2 Minutes Predict Fluid Responsiveness for Pediatric Patient? N/A
Completed NCT05386082 - Anesthesia Core Quality Metrics Consensus Delphi Study
Terminated NCT03567928 - Laryngeal Mask in Upper Gastrointestinal Procedures N/A
Recruiting NCT06074471 - Motor Sparing Supraclavicular Block N/A
Completed NCT04163848 - CARbon Impact of aNesthesic Gas